Tax Benefit Boosts Bristol's Profit

Bristol-Myers Squibb's fourth-quarter profit rose 8.6% on a tax benefit, while sales tumbled 23% due to generic competition for the company's former top product, the anti-clotting drug Plavix.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news